Centrica (LSE:CNA) EPS Jump Draws Focus, Is It Still 25% Below Fair Value?

Centrica (LSE:CNA) is back in focus after a very large jump in earnings per share, coupled with modest 0.6% revenue growth and a £1.5b net cash position that supports its 3.76% dividend yield.

Recent trading has been mixed. The share price is up 4.63% over the past month, but the year-to-date share price return is down 11.16%. The 5-year total shareholder return of 161.68% points to investors rewarding Centrica over a longer horizon as confidence builds around its earnings recovery, nuclear exposure and regulated infrastructure focus.

Scan beyond Centrica and line up other regulated energy and infrastructure players by running the hand curated 42 power grid technology and infrastructure stocks in the same session while this thesis is fresh.

Centrica’s shares have barely moved this year while analyst targets and intrinsic value estimates sit meaningfully higher. Is the recent 4.63% bounce the start of that gap closing or already enough?

Most Popular Narrative: 25% Undervalued

Centrica closed at £1.55 while the analyst consensus Narrative on Simply Wall St puts fair value at £2.06, using a 7.56% discount rate and tying that to detailed earnings and infrastructure assumptions.

The main thing that has to go right is that Centrica continues to execute on its capital recycling into Sizewell C, Grain LNG, the Meter Asset Provider and CCGTs while keeping bad debt, working capital and optimization volatility under control.

The current valuation implies that the market is treating Centrica’s planned £1.7b to £2b EBITDA targets and the shift toward regulated and contracted earnings as only partly reflected in the share price, even after the roughly 29% share price sell off since April 2026.

See why 52 investors see Centrica as 25% undervalued.

Result: Fair Value of £2.06 (UNDERVALUED)

Still, rising retail bad debt and the wider £7b UK energy arrears, along with the risk around future regulation, could quickly challenge the Centrica undervaluation story.

Find out about the key risks to this Centrica narrative.

Next Steps

Whether you prefer a forward-looking or cautious approach, you should assess Centrica’s mix of earnings recovery, regulation risk and infrastructure upside against your own expectations, then weigh the 5 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Centrica?

If Centrica has sharpened your focus on quality, do not stop here. Broaden your watchlist with other clear, data backed ideas worth your attention.

• Target income resilience by reviewing companies that feature generous yields and solid coverage through the 4 dividend fortresses.
• Look for quality at a sensible price with the 17 high quality undervalued stocks, built to highlight stocks where fundamentals and valuation both appear attractive.
• Limit potential downside by scanning the 5 resilient stocks with low risk scores, a curated set of businesses with comparatively sturdy risk profiles that some investors may overlook.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com